Japan.
Since secretin was discovered by Bayliss and Starling in 1902 (1) , little attention has been given to the nervous control of pancreatic secretion. About twenty years later, Mal lanby (2) suggested that the vagus nerves regulated enzyme output, while secretin con trolled the flow of pancreatic juice. This theory found general acceptance until Harper and Raper (3) discovered another pancreatic hormone, pancreozymin, in 1943. Thus, it has been assumed that the external secretory activity of the pancreas is mainly controlled by these hormones, while the secretory nerve plays a relatively subsidiary role. Recently, however, Hickson (4, 5) showed in the pig, that either stimulation of the vagus nerve or intra-arterial injection of acetylcholine produced a profuse flow of pancreatic juice rich in bicarbonate and poor in enzymes. He suggested that the parasympathetic, secretory nerve supply exerted a quantitatively greater influence on the external secretion of the pan creas. On the other hand, it is accepted that the sympathetic nerve supply and also sym pathomimetic agents inhibit secretion of pancreatic juice. Recently, the authors found that dopamine, one of the naturally occurring catecholamines, caused a marked flow of juice with a high content of bicarbonate in the isolated and blood-perfused canine pancreas (6). Since the canine pancreas demonstrated secretion in the resting state, elucidation of the vascular and secretagogue responses to various biogenic and foreign substances was at tempted.
MATERIALS AND METHODS
Fifty-six adult mongrel dogs of both sexes, weighing 9 to 18 kg were used. These animals were provided water only ad fibitarm for 24 hr before the experiments.
The dogs were anaesthetized with 30 mg/kg of sodium pentobarbitone and additional intramuscular doses of 10 mg/kg were given every hour. A tracheal tube was inserted and animals were artificially ventilated with air. The operative procedure has already been reported in detail (6). The main pancreatic duct was carefully isolated close to the duodenum. The minor papilla was identified after a longitudinal incision had been made in the duodenal wall. A polyethylene tube (I.D. 0.8 mm, O.D. 1.35 mm) was inserted through the papilla into the main pancreatic duct. The tube was ligated tightly and con nected to a drop counter. The accessory pancreatic duct was ligated and cut.
Isolation of the pancreatic circulation was carried out as follows. The gastroduodenal artery was isolated first, preserving perivascular nerves as far as possible. The right gas tric and the right gastroepiploic arteries arising from the gastroduodenal artery were ligated. The duodenum was divided about 1 cm from the pylorus. The gastric branches of the splenic artery were successively ligated, after which the spleen was removed. Next, vas cular connections between the pancreas and the duodenum were carefully ligated and cut. Bile was drained off through a tube inserted into the bile duct. An initial dose of heparin, 300 units/kg was given and a maintenance dose, 100 units/kg was added hourly. An arterial cannula was inserted into the gastroduodenal artery which was perfused with the arterial blood pumped from the left femoral artery. The inferior pancreaticoduodenal artery was then ligated. The splenic artery was also cannulated and perfused retrogradely with blood from the femoral artery. Finally, the splenic artery was ligated at the point of origin, care being taken not to injure the perivascular nerves and to preserve the left gastric artery. With these procedures, the whole pancreas was perfused by the two arterial cannulae without any danger of interruption of the blood supply to the pancreas. Blood supply to the liver and the stomach was unaffected.
Arterial blood, led from the left femoral artery was pumped into both cannulated arteries of the pancreas with a variable speed pump (Harvard Apparatus, Model 1215).
The perfusion pressure was maintained at 100 mmHg by means of a Starling pneumatic resistance, draining an excess of blood to the femoral vein. Blood to the pancreas was measured by an electromagnetic flowmeter (Nihon Kohden, MF-2) and the flow of pan creatic juice was measured by a drop counter. Systemic blood pressure and the perfusion pressure were measured by electromanometers (Nihon Kohden, MP-24T).
The incised abdomen was covered with poly-vinyl sheet and warmed by an electric lamp so that the exposed pancreas was kept moist. Rectal temp. was maintained at 38-39`C. The pancreas responded well to repeated doses of secretin during an experiment lasting more than 4 hr. Pancreatic juice was calculated according to the number of drops, utiliz ing a drop counter. One milliliter of distilled water corresponded to 70 drops. Drug solutions were injected into the tubing led to both arterial cannulae. Microsyringes (Jintan Terumo Co.) were used to inject 10 or 30 ,rtl of drug solution in a period of 4 or 12 seconds, respectively.
Drugs, manufacturing pharmaceutical laboratories, doses and number of animals were as follows. Cholinergic drugs: acetylcholine chloride (Daiichi) 1-100 /,tg, n=51; methacholine chloride (Merck) 10-100 peg, n-11; carbachol chloride (K & K Lab.) 1-100 Itg, n=l l ; bethanechol chloride (Eisai) 10-100 gtg, n 14; physostigmine salicylate (Merck) 10-300 ieg, n-6; pilocarpine hydrochloride (Daiichi) 10-100 /tg, n=6; lobeline hydro chloride (Dainippon) 10-100 ,ug, n-7; nicotine sulfate (Tokyo Kasei) 10-100 geg, n=10; tetramethylammonium chloride (TMA, Tokyo Kasei) 10-100 ,tg, n=7 Nucleosides and nucleotides: adenosine (Boehringer) 10 It to I mg, n ---8; adenosine 5'-monophosphate disodium (AMP, Sigma) 10 It to 1 mg, n= 7; adenosine-5'-diphosphate trisodium (ADP, Waldhof) 10 ,teg to I mg, n 7; adenosine-5'-triphosphate disodium (ATP, Sigma) 10,ttg to 1 mg, n-8; uridine (Tokyo Kasei) 100 It-, n--5; uridine-5'-nmono phosphate disodium (U M P, Waldhof) 100 /tg, n7-6; uridine-5'-diphosphate disodium (UDP, Waldhof) 100 It-, n--6; uridine-5'-triphosphate trisodium (UTP, Derivatti Biologica S.P.A.) 100 geg, n---6; diphosphopyridine nucleotide (DPN, Sigma) 100-300 gig, n=6; triphosphopyridine nucleotide (TPN, Nutritional Biochemical Corp.) 100-300 /tg, n-=6; adenosine-3', 5'-cyclic monophosphate (cyclic AMP, Sigma) 10 Itg to I mg, n5; N"-2' O-dibutyryl-adenosine-3', 5'-monophosphate (dibutyryl cyclic AMP, Sigma) 100 /eg to 3 mg, n 5.
Biogenic amines: histamine dihydrochloride (Daiichi) 1-30 ppg, n=17; 5-hydroxy tryptamine creatinine sulfate (5-HT, Wako) 1-100 ,ng, n --9.
Methylxanthines: caffeine sodium benzoate (Takeda) 100/1 to 10 mg, n=12; theo phylline ethylenediamine (Eisai) 1001ig to 10 mg, n=10; theobromine calcium salicylate (Tanabe) 100 /tg to 10 mg, n 10. Miscellaneous drugs: tetraethylammonium bromide (TEA, Kowa) 100 pg, n=4;
Res. Lab.) 10 1-10, to 3 mg, n= 17; nitroglycerin (Nippon Kayaku) 10-1001pg, n-7; papaverine hydrochloride (Tokyo Kasei) 10-100 1,tg, n=5; dipyridamole (Boehringer) 10-100 1tg, n=5, verapamil (Eisai) 3-30 /eg, n-6; hydralazine hydrochloride (Ciba) 10-300 /eg, n-4; cocaine hydrochloride (Takeda) 30100pq-1, n---5; procaine hydrochloride (Daiichi) 1001-tg, n-4; tolazoline (Yamanouchi) 10-100 /to, n-5; morphine hydrochloride (Takeda) 30-100 pg, n=4; ergota mine tartarate (Wako) 10-100 ptg, n-5; ouabain (Takeda) 3-10 /pg, n-4; strospeside (Shionogi) 10-100 /ig, n 4. All drugs were dissolved in 0.9()./ NaCI solution immediately before use. I-Nor adrenaline and /-adrenaline were dissolved in 1/100 N HCl at a concentration of 1 mg/ml, and diluted with 0.9% NaCI solution.
Doses of secretin, pancreozymin, insulin and kallikrein are expressed in terms of unit. Oxytocin and lysine-vasopressin are expressed in terms of It-. One microgram of oxyto cin corresponds to 0.46 IU (oxytocin activity), and I pg of lysine-vasopressin to 0.27 IU (pressor activity).
RESULTS

Perfusion flow and pancreatic secretory rate under resting conditions
In 56 experiments, the rate of the pancreatic blood flow was 11.4±0.5 ml/min (mean S.E.). A sparse flow of pancreatic juice was observed in most preparations under resting conditions, the mean rate being 11.9_;_0.91d/minute. The average wt. of the pancreas measured at the end of each experiment was 53.8 1-1.8 grams. Thus, the mean value of the perfusion flow rate per wt. was 0.21 ml/min/g.
Secretory and vascular responses to various substances
Secretory and vascular responses to the drugs mentioned above are presented in Table 1 . All values are expressed by mean S.E. The output of juice is expressed as increase or decrease from resting flow of juice, and the duration of secretion is presented as the interval of time from injection of the drug to when secretion returned to a resting level.
Change in the rate of blood flow is expressed as the percentage of maximum increase or decrease from the resting flow rate. Duration of vascular responses is determined by the time required until the flow rate returned to a resting condition. Several drugs such as DMPP, 5-HT and hydralazine caused an initial transient vasodilatation followed by a prominent long-lasting vasoconstriction. Dopamine constricted the pancreatic vascular Volume changes of pancreatic juice are shown in terms of tel. Maximum changes of blood flow rate are indicated in percent changes. Each value represents the mean and standard error. Each compound was injected intra-arterially by a microsyringe. L-Dopa was infused intra-arterially at a constant rate of 100 og,''min. *Vascular re sponses to ergotamine, ouabain and strospeside lasted more than 2000 sec.
(1) Cholinergic drugs ( Fig. 1 , Table 1) a) Effect on the secretion of'pancreatic juice: Typical responses to cholinergic drugs are illustrated in Fig. 1 . Cholinesters, i.e., acetylcholine, methacholine, carbachol and bethanechol, caused an apparent increase of pancreatic secretion at a dose of 10 ppg.
Methacholine and carbachol elicited a relatively long-lasting secretion of the pancreatic juice. The relative potency of these cholinergic drugs was in the descending order of car bachol, bethanechol, methacoline and acetylcholine. Pilocarpine also produced an ap parent and long-lasting increase of the pancreatic juice at a dose of 30 pig. Cholinesterase inhibitors, i.e., physostigmine and neostigmine caused an apparent increase of pancreatic secretion at a dose of 100 /pg. The secretooy potency of neostigmine was about twice that of physostigmine. Ganglion stimulants, i.e., lobeline, nicotine, TMA and DMPP showed a slight in crease of secretion up to a dose of 100 pg, although McN-A-343 elicited a definite flow of juice at a dose of 100 jag. b) Effect on vascular beds of the pancreas: Acetylcholine, methacholine, carbachol and bethanechol dilated the vascular beds, causing a marked increase in the flow rate of perfusion. Vascular effects induced by methacholine and carbachol continued longer than those by acetylcholine and bethanechol. Pilocarpine caused a vasodilatation. Neo stigmine caused a long-lasting vasodilatation, while physostigmine constricted the pan creatic vascular beds.
Ganglion stimulants, i.e., lobeline, nicotine, TMA and McN-A-343, caused a slight vasodilatation at a dose of 100 pg, while DMPP caused an initial transient vasodilatation followed by a slight long-lasting vasoconstriction.
(2) Adrenergic drugs (Fig. 2 , Table 1) a) Effect on the secretion of pancreatic juice: Dopamine, one of the naturally occurring catecholamines, caused a profuse output of juice with a threshold of I pg as previously reported (6), however, noradrenaline and adrenaline had almost no effect on the external secretion at a dose of 0.3 pg. Although these catecholamines caused a slight and tran sient decrease in output of pancreatic juice at a dose of 1 pg, isoprenaline had no effect up to a dose of 3Iig. Other sympathomimetic amines, phenylephrine, methoxamine, ephedrine and tyramine, had no effect on pancreatic secretion. b) Effect on vascular beds of the pancreas: Dopamine usually constricted the pan creatic vascular beds but this was occasionally followed by a slight vasoconstriction. Nor adrenaline and adrenaline caused a vasoconstriction at doses of 0.1 to 0.3 pg. Injection of I pg of adrenaline frequently caused a diphasic vascular effect, that is considerable vaso constriction followed by a brief vasodilatation. Isoprenaline dilated the pancreatic vas cular beds. Ephedrine and tyramine caused a long-lasting vasoconstriction compared to that observed with phenylephrine and methoxamine.
(3) Gastrointestinal hormones and active polypeptides (Fig. 3, Table 1 ) a) Effect on the secretion of pancreatic juice: Either secretin (Jorpes) or secretin (Boots) elicited a profuse output of pancreatic juice. Almost the same secretagogue ac tivity was observed at a dose of 0.03 units of secretin (Jorpes) and 0.3 units of secretin (Boots). Pancreozymin caused a moderate increase of pancreatic secretion. Gastrin induced secretion of the pancreatic juice. Glucagon, one of the islet hormones of the pancreas, had no effect at doses from 1 to 3 ug, while at doses higher than 10 pg, the flow rate of pancreatic juice was increased. Insulin had no effect on pancreatic secretion. (4) Nucleosides and nucleotides (Fig. 4 . Table 1) a) Effect on the secretion of pancreatic juice: Adenosine, AMP, ADP and ATP had no effect on the secretion at doses up to I neg. Uridine, UMP, UDP, UTP, DPN and TPN given in doses ranging up to 300 pg, did not effect the secretion.
Cyclic AMP at a dose of 1 mg, had no effect on pancreatic secretion, however, di butyryl cyclic AMP caused a definite increase of the pancreatic secretion dose-dependently at doses from 300 fig to 3 mg within 2-3 min after administration and lasted for approx.
20 min as illustrated in Fig. 4 . While the effect of cyclic AMP on the pancreatic vascular beds was very weak, a dose of 1 mg did result in a vasodilatation. Dibutyryl cyclic AMP caused a slight but long lasting vasodilatation at doses ranging from 300 fag to 3 mg.
(5) Biogenic amines (Fig. 5 , Table 1 ) Histamine dilated the pancreatic vascular beds and caused a moderate secretion of pancreatic juice. 5-HT had no effect on the secretion at doses up to 100 pg. The ob served vascular effect was an initial transient vasodilatation followed by a slight but long lasting vasoconstriction. (7) Miscellaneous drugs (Fig. 7 , Table 1 ) a) Effect on the secretion of pancreatic juice : Responses to miscellaneous com pounds investigated in this study are presented in Fig. 7 . L-Dopa, the precursor of dopa mine, produced a long-lasting secretion, when infused intra-arterially at a constant rate of 100 ,ug/min. Nitroglycerin, at doses from 10 to 100 jig, caused an apparent dose-depen dent increase in the secretion. All other agents investigated had no effect on the secretion. b) Effect on vascular beds of the pancreas: As shown in Fig. 7 , nitroglycerin, papa verine, dipyridamole and verapamil dilated the pancreatic vascular beds, however, the vascular effect of hydralazine was an initial vasodilatation followed by a definite vaso constriction. TEA, procaine and tolazoline resulted in a slight vasodilatation. Cocaine constricted pancreatic vascular beds at a dose of 100,ug. L-Dopa and morphine had no effect on the pancreatic vascular beds. Ergotamine caused an initial slight vasodilata tion followed by a long-lasting vasoconstriction for more than 30 min. Ouabain, 10 pg, and strospeside, 100 pppg, constricted the pancreatic vascular beds for more than 30 min as did ergotamine. (Table 2) Various drugs investigated in this study were classified on the basis of the effects on both pancreatic secretion and pancreatic vascular beds. The majority of drugs which increased the output of pancreatic juice, including most of cholinergic drugs and gastro intestinal hormones, caused vasodilatation, however, bradykinin and kallikrein inhibited secretion in spite of prominent vasodilatation, and DMPP, physostigmine and dopamine increased the secretion with vasoconstriction. Vasopressin decreased output rate of pan creatic juice and rate of blood flow. (Table 3) Responses of the pancreatic vascular beds to various drugs were compared with those of other peripheral arteries, i.e., the coronary, renal, mesenteric and femoral arteries which had been investigated in this laboratory (7) . As indicated in Table 3 , responses of the pancreatic artery to various drugs were found to be similar to those of the mesenteric artery except those to tolazoline, nicotine and lobeline which constricted the mesenteric artery and dilated the pancreatic vascular beds. 5. Dose response curves of some of the effective drugs (Fig. 8, Table 1 ) Dose response curves of some of the effective drugs are demonstrated in Fig. 8 . Vol ume changes of pancreatic juice are shown in terms of p l, and maximum changes of blood flow rate are indicated in percent changes. Doses of secretin (Jorpes) were calculated from the report by Vague et al. (8) and expressed in terms of pig. According to the re sults of those authors, one microgram of a weighable sample of natural secretin corresponds to either 3.4 units (clinical unit) of highly purified secretin or one microgram of the new preparation of synthetic secretin made by Onditti.
Classification of investigated drugs
Secretin (Jorpes) was the most potent secretagogue among the drugs investigated herein.
Secretin (Jorpes) had approx. a thousand times the potency of dopamine in the weight basis. Dopamine was the next most potent secretagogue and elicited a marked increase of pancreatic juice in a dose range from 1 to 10 /eg with a slight vasoconstriction. Hista mine and gastrin caused a slight increase of output of pancreatic juice at the same dose range and a marked vasodilatation. Nitroglycerin, bethanechol, McN-A-343 and glu cagon showed almost the same secretory and vascular activity in a dose range from 10 to 100 ,ceg dose-dependently. Dibutyryl cyclic AMP caused an apparent increase of out put of pancreatic juice with slight vascular changes in a dose range from 300 ,ug to 3 mg, while theophylline produced an slight increase of output of pancreatic juice with marked vascular changes in doses from 1 to 10 mg. There was no parallel relation between the secretion of pancreatic juice and localized blood flow in the majority of drugs tested. 
DISCUSSION
As isolated perfusion with blood allows for a more precise investigation of the secre tory mechanism of the pancreas, attempts to utilize such a method have been made by sever al investigators.
Babkin and Starling (9) first described an experiment in which a canine pancreas was perfused by way of the superior pancreaticoduodenal artery using a heart lung preparation. Nardi et al. (10) utilized the pancreatic perfusion and studied the secre tory mechanism of isolated pancreas. In this investigation, the authors investigated a preparation of isolated canine pancreas which was perfused ill situ with the animal's own blood conducted from the femoral artery to the gastroduodenal and splenic arteries under a constant pressure of 100 mmHg. Using these blood-perfused preparations, the mecha nism of pancreatic secretion could be analyzed together with a simultaneous observation on the circulatory response.
Drugs that augment or inhibit the action of the exocrine pancreas have been tested in order to elucidate the control mechanism of secretion of the pancreas (11) . Since the discoveries of secretin (1) and pancreozymin (3), it has been assumed that the external secretion of the pancreas is mainly regulated by those hormones and with the nervous regulation acting as a subsidiary. Recently, it was demonstrated in the pig, that the vagal stimulation and several cholinergic agents produced a profuse flow of pancreatic juice (4, 5) and in the cat (12) . It was claimed that the cholinergic stimulation appeared to exert a wide and quantatively greater influence on the external pancreatic secretion. In this report, acetylcholine and other cholinergic agents, except ganglion stimulants, pro duced an apparent increase in the output of pancreatic juice. This suggests that choliner gic innervation plays an important role in the exocrine pancreatic secretion in the dog as well as in the cat and the pig.
Adrenergic drugs in a resting condition had almost no effect on the secretion except for dopamine which caused a profuse flow of juice as has been previously reported (6). The increase of secretion induced by dopamine was much greater than that induced by cholinergic drugs. The juice secreted by dopamine is rich in bicarbonate and poor in enzymes (13) , this being very similar to the effects of secretin. Secretin (Jorpes) was ex tremely potent in causing secretion. This may indicate that the external regulation is superior to the nervous control. But, pancreatic secretory hormones such as secretin and pancreozymin are released from the intestine, enter the systemic circulation and a small amount reaches the pancreas. On the other hand, autonomic transmitters such as acetylcholine, noradrenaline or perhaps dopamine are near effector cells and act directly to these effector cells to produce stimulation. Thus, it cannot be concluded, that the role of autonomic innervation is negligible when a comparative study on the secretagogue effect obtained by the direct application through the pancreatic artery is carried out.
Highly purified secretin caused a vasodilatation as well as Boots secretin. Hilton and Jones (14) investigated functional vasodilatation and suggested that this vasodilata tion is due to released kinin substances, however, in the present study, secretin elicited secretion at a dose of 0.01 unit without any vasodilatation, and at a dose of 0.1 unit, the secretion continued even after cessation of vasodilatation. For this reason, secretin it self appears to have a vasoactive property independent of the secretory effect.
Gastrin caused an increase in the flow rate of pancreatic juice. This result supports the observations of Preshaw and Grossman (15) that gastrin effected the pancreatic secre tion in the dog. It is already known that the polypeptide terminal of pancreozymin is structurally similar to that of gastrin. Gastrin may stimulate pancreatic secretion under the same mechanism with which pancreozymin caused pancreatic secretion.
It has recently been reported by Dyck et al. (16) that glucagon produced no signifi cant stimulation of secretion in the resting gland but markedly depressed the volume flow in the stimulated gland. In this study, glucagon elicited an increase of secretion at doses from 10 to 100 ,ug. Previously, Necheles (17) observed that glucagon caused an increase of pancreatic secretion followed by the prolonged inhibition of secretion. Thus, the effect of glucagon on the exocrine pancreas may be modified by different experimental conditions.
Vasopressin markedly inhibited the resting flow of the pancreatic juice thus differing from angiotensin and oxvtocirn which caused a long-lasting vasoconstriction with only a slight inhibition of secretion at a dose of I ttg. Bradykinin also caused a slight inhibi tion of secretion with a considerable vasodilatation. The inhibitory effect of vasopressin on the pancreatic secretion has been reported by Banks et al. (18) , however, the mecha nism of action of these polypeptides including vasopressin remains obscure.
Cyclic AMP, which is considered the second messenger of hormonal effect on the target cells since the time of Sutherland's hypothesis in 1965 (19) , failed to cause pancrea tic secretion in doses up to 1 neg. Dibutyryl cyclic AMP, however, caused an apparent increase of secretion which continued more than 20 min with a dose of 300 gig. Dibutyryl cyclic AMP is generally used as one of derivatives of cyclic AMP for two reasons, i.e., it permeates cell membrane more easily and is less easily destroyed by phosphodiesterase than is cyclic AMP. Recently, Case et al. (20) observed an increase of output of pan creatic juice after the administration of dibutyryl cyclic AMP in the perfused cat pancreas.
In this study, it was confirmed that there is an apparent increase of secretion with dibutyryl cyclic AMP. This suggests that cyclic AMP may play some role in the mechanism of pancreatic secretion as a second messenger of hormonal function. Methylxanthines such as caffeine, theophylline and theobromine caused an increase of secretion at doses from 1 to 10 mg. These effects may be explained by the increased amount of cyclic AMP in the secretory cells, since methylxanthines are generally thought to inhibit the diesterase responsible for the breakdown of cyclic AMP (21) .
Histamine secreted pancreatic juice as previously reported by Tankel cat al. (22) , while 5-HT has no effect on secretion. The role of histamine and 5-HT in the exocrine pancreas remains to be elucidated.
Among other drugs, L-Dopa, a precursor of dopamine in the adrenergic nerve termi nals, caused an increase of secretion. This may be the effect of the dopamine transformed by dopa decarboxylase (6). Nitroglycerin also has a secretory effect on the exocrine pan creas. Barlow (23) investigated the effect of nitrates on the exocrine pancreas and assumed the effect was due to vasodilatation. Our results suggest that this effect is due to some unknown mechanism rather than to vasodilatation, since the other vasodilators did not elicit an increase of the pancreatic juice output.
A consideration of the relationship between pancreatic secretion and local blood flow was made. Claude Bernard (24) first pointed out that during digestion the pancreas be came congested and red. In 1957, Tankel and Hollander (25) again reviewed literature after this observation. They concluded that there was no adequate data to establish association between pancreatic secretion and an increase in blood flow to the pancreas. Eichelter and Schenk (26) and Goodhead et al. (27) suggested an association between secre tion and increased blood flow, but such a postulation is not in agreement with the drug responses observed in the experiments herein. As presented in Fig. 8 , secretin (Jorpes) was the most potent secretagogue, while it has a little vasodilating effect. Histamine caused a slight increase in secretion of pancreatic juice and a marked vasodilatation. In addition, agents with vasodilator effects such as isoprenaline, bradykinin, eledoisin, ATP, dipyrida mole and verapamil did not re3ult in any increase in pancreatic secretion. Thus, the secre tion of pancreatic juice does not change in parallel with the rate of local blood flow. From these results, it is concluded that pancreatic secretion may be stimulated independently from the blood supply to the organ.
